Filed: 2/12/2026ACC: 0001123292-26-000164
📋 What this filing means
GILEAD SCIENCES, INC. filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $1.94B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$1.94B
Total AUM (reported)
72.59M
Total Shares
Allocation by class
COM$793.47M41.0%
SPON ADR$550.62M28.4%
COMMON STOCK$438.20M22.6%
COM NEW$153.23M7.9%
Portfolio Concentration
Top 3$1.74B89.8%
4–10$197.84M10.2%
Top 3 weight
89.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 72.59M
Sole
Full voting authority
72.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
ARCUS BIOSCIENCES INC
SOLEShares31.42M
TypeSH
Market value$748.85M
38.69%
Sole
31.42M
Shared
0.00
None
0.00
GALAPAGOS NV
DFNDShares16.71M
TypeSH
Market value$550.62M
28.45%
Sole
16.71M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares6.72M
TypeSH
Market value$438.20M
22.64%
Sole
6.72M
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares4.51M
TypeSH
Market value$153.23M
7.92%
Sole
4.51M
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares4.13M
TypeSH
Market value$38.79M
2.00%
Sole
4.13M
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares9.11M
TypeSH
Market value$5.83M
0.30%
Sole
9.11M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCUS BIOSCIENCES INCSOLE | COM | 31.42M | SH | $748.85M 38.69% | 31.42M | 0.00 | 0.00 |
GALAPAGOS NVDFND | SPON ADR | 16.71M | SH | $550.62M 28.45% | 16.71M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 6.72M | SH | $438.20M 22.64% | 6.72M | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 4.51M | SH | $153.23M 7.92% | 4.51M | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 4.13M | SH | $38.79M 2.00% | 4.13M | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 9.11M | SH | $5.83M 0.30% | 9.11M | 0.00 | 0.00 |